Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Carfilzomib in Adult Patients With Relapsed Acute Myeloid and Acute Lymphoblastic Leukemia

NCT01137747 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01137747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01137747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Carfilzomib in Adult Patients With Relapsed Acute Myeloid and Acute Lymphoblastic Leukemia
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2010
Completion date
July 31, 2015
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia